The DOI matches its Crossref record.
Interrelationship of Glucagon, Insulin and Glucose: The Insulinogenic Effect of Glucagon
Abstract
Glucagon in doses of 0.25 or 1.0 mg. was injected rapidly, intravenously, into healthy normal subjects. There was a striking rise in arterial immunoreactive insulin levels within one minute of the start ot the injection before any change in arterial glucose concentration occurred Plasma insulin levels reached their peak within ten minutes and began to fall thereafter. In contrast, blood glucose levels were highest twenty to thirty minutes after the injection. A second glucagon injection during the hyperglycemic phase produced a larger rise in plasma insulin than the first. During constant infusions of smaller amounts of glucagon, the insulinogenic effect of glucagon was usually only apparent if blood glucose levels were raised. The effect of consecutive forty-minute intravenous infusions of glucagon (10μg./min.), glucose (0.5 gm./min.) and a glucagon-glucose (5μg. and 250 mg./min., respectively) on plasma insulin and arterio-venous blood glucose differences in six healthy normal subjects was studied. Plasma insulin levels were two to five times higher during glucose infusions alone, despite similar peak arterial blood glucose levels during the infusions. Similar results were obtained in other subjects during separate infusions of glucose and glucagon. Total body glucose clearance, judged by the rate of fall in arterial blood glucose levels, was faster after glucagon- than after glucose-induced hyperglycemia. Forearm A-V blood glucose differences were not obviously greater during glucagon, in spite of the higher plasma insulin levels, than during glucose infusions. Possible reasons for the failure of forearm A-V blood glucose differences to reflect accurately total peripheral glucose assimilation under these experimental conditions are discussed, and it is suggested that the co-existence of hyperglucagonemia and hyperinsulinemia may tend to favor incorporation of glucose into adipose tissue rather than muscle. Plasma glucagon levels were measured by immunoassay and the half-life was about ten minutes. The results provide evidence of a direct effect of glucagon upon insulin secretion. The suggestion is made that the insulinogenic effect of glucagon is physiological importance and is due to accelerated intra-β-cell glycogenolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
GLUCOSE TOLERANCE AND DIABETES IN CHRONIC LIVER DISEASE
Megyesi, C., Samols, E., & Marks, V. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90334-0 · Cited by 356
Self-citationDiGruccio, M. R., Mawla, A. M., Donaldson, C. J., Noguchi, G. M., Vaughan, J., Cowing-Zitron, C., van der Meulen, T., & Huising, M. O. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.04.007 · Cited by 353
Insulin release: The fuel hypothesis
Malaisse, W. J., Sener, A., Herchuelz, A., & Hutton, J. C. (1979) · Metabolism · doi:10.1016/0026-0495(79)90111-2 · Cited by 342
Tan, T. M., Field, B. C. T., McCullough, K. A., Troke, R. C., Chambers, E. S., Salem, V., Gonzalez Maffe, J., Baynes, K. C. R., De Silva, A., Viardot, A., et al. (2013) · Diabetes · doi:10.2337/db12-0797 · Cited by 258
Gerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V, Karam, J. H., & Forsham, P. H. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108364 · Cited by 198
Metadata
- Authors
- Samols, E., Marri, G., & Marks, V.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1966-12-01
- Volume
- 15
- Issue
- 12
- Pages
- 855-866
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2126411608
- Cited by
- 199
- References
- 0
- FWCI
- 52.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interrelationship of Glucagon, Insulin and Glucose: The Insulinogenic Effect of Glucagon. https://app.cochat.ai/papers/10.2337/diab.15.12.855
- The paper
- Samols, E., Marri, G., & Marks, V. (1966). Interrelationship of Glucagon, Insulin and Glucose: The Insulinogenic Effect of Glucagon. Diabetes. https://doi.org/10.2337/diab.15.12.855
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.